These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 21944891)

  • 1. The relative lung and systemic bioavailability of terbutaline following nebulisation in non-invasively ventilated patients.
    Abdelrahim ME; Plant PK; Chrystyn H
    Int J Pharm; 2011 Nov; 420(2):313-8. PubMed ID: 21944891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions.
    Abdelrahim ME
    Respir Med; 2010 May; 104(5):682-9. PubMed ID: 20004090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro characterisation of the nebulised dose during non-invasive ventilation.
    Abdelrahim ME; Plant P; Chrystyn H
    J Pharm Pharmacol; 2010 Aug; 62(8):966-72. PubMed ID: 20663030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation.
    Chege JK; Chrystyn H
    Respir Med; 2000 Jan; 94(1):51-6. PubMed ID: 10714479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salbutamol relative lung and systemic bioavailability of large and small spacers.
    Mazhar SH; Chrystyn H
    J Pharm Pharmacol; 2008 Dec; 60(12):1609-13. PubMed ID: 19000365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease.
    Chong CF; Chen CC; Ma HP; Wu YC; Chen YC; Wang TL
    Emerg Med J; 2005 Jun; 22(6):429-32. PubMed ID: 15911951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion.
    Abdelrahim ME; Assi KH; Chrystyn H
    Br J Clin Pharmacol; 2011 Apr; 71(4):608-10. PubMed ID: 21395654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative lung and systemic bioavailability of sodium cromoglycate inhaled products using urinary drug excretion post inhalation.
    Aswania O; Chrystyn H
    Biopharm Drug Dispos; 2002 May; 23(4):159-63. PubMed ID: 12015790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic availability and lung deposition of budesonide via three different nebulizers in adults.
    Dahlström K; Thorsson L; Larsson P; Nikander K
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):226-32. PubMed ID: 12602671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terbutaline Accumulates in Blood and Urine after Daily Therapeutic Inhalation.
    Krogh N; Rzeppa S; Dyreborg A; Dehnes Y; Hemmersbach P; Backer V; Hostrup M
    Med Sci Sports Exerc; 2017 Jun; 49(6):1236-1243. PubMed ID: 28072631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung deposition after inhalation with various nebulisers in preterm infants.
    Köhler E; Jilg G; Avenarius S; Jorch G
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F275-9. PubMed ID: 18192330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced delivery of nebulised salbutamol during non-invasive ventilation.
    Calvert LD; Jackson JM; White JA; Barry PW; Kinnear WJ; O'Callaghan C
    J Pharm Pharmacol; 2006 Nov; 58(11):1553-7. PubMed ID: 17132219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of inhalational bronchodilator treatment during noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations.
    Mukhopadhyay A; Dela Pena E; Wadden B; Procyshyn M; Keang Lim T
    J Crit Care; 2009 Sep; 24(3):474.e1-5. PubMed ID: 19664528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the Next Generation Impactor.
    Abdelrahim ME
    Pharm Dev Technol; 2011 Apr; 16(2):137-45. PubMed ID: 20100034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placement of the nebulizer before the humidifier during mechanical ventilation: Effect on aerosol delivery.
    Moraine JJ; Truflandier K; Vandenbergen N; Berré J; Mélot C; Vincent JL
    Heart Lung; 2009; 38(5):435-9. PubMed ID: 19755194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks.
    de Matas M; Shao Q; Richardson CH; Chrystyn H
    Eur J Pharm Sci; 2008 Jan; 33(1):80-90. PubMed ID: 18035525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival according to ventilation mode in acute respiratory failure secondary to chronic obstructive pulmonary disease: a multicenter, inception cohort study.
    Berkius J; Sundh J; Nilholm L; Fredrikson M; Walther SM
    J Crit Care; 2010 Sep; 25(3):539.e13-8. PubMed ID: 20381291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of nebulised and inhaled salbutamol on breathlessness in severe COPD.
    Poole PJ; Saini R; Brodie SM; Black PN
    Respir Med; 2005 Mar; 99(3):372-6. PubMed ID: 15733514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.